Are Patients Taking Oral Cancer Regimens as Prescribed?
September 23rd 2013Between 21% and 28% of patients taking an oral therapy for hepatocellular carcinoma (HCC) were nonadherent to treatment. Certain groups of patients may benefit from counseling services that promote improved adherence.
Read More